All lobbying filings

CROSSROADS STRATEGIES, LLC

Lobbying for INDIVIOR INC. · pharmaceutical company

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · California · House · Senate · $50,000.00 income · posted Oct 19, 2025

Official filing document

Bills named in this filing 5

HR 5304
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026
S 2587
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026
HR 5342
Commerce, Justice, Science, and Related Agencies Appropriations Act, 2026
S 2354
Commerce, Justice, Science, and Related Agencies Appropriations Act, 2026
HR 1
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.

Lobbying activity 2

Pharmacy

Issues related to overdose reversal products including Naloxone; FY2026 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act (H.R.5304/S.2587); FY2026 Commerce, Justice, Science, and Related Agencies Appropriations Act (H.R.5342/S.2354).

Medicare/Medicaid

Medicaid policies related to substance use disorder; H.R.1, One Big Beautiful Bill Act (P.L.119-21).

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.